| D009336 |
Necrosis |
The death of cells in an organ or tissue due to disease, injury or failure of the blood supply. |
|
|
| D005260 |
Female |
|
Females |
|
| D005901 |
Glaucoma |
An ocular disease, occurring in many forms, having as its primary characteristics an unstable or a sustained increase in the intraocular pressure which the eye cannot withstand without damage to its structure or impairment of its function. The consequences of the increased pressure may be manifested in a variety of symptoms, depending upon type and severity, such as excavation of the optic disk, hardness of the eyeball, corneal anesthesia, reduced visual acuity, seeing of colored halos around lights, disturbed dark adaptation, visual field defects, and headaches. (Dictionary of Visual Science, 4th ed) |
Glaucomas |
|
| D006801 |
Humans |
Members of the species Homo sapiens. |
Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man |
|
| D000328 |
Adult |
A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. |
Adults |
|
| D015422 |
Scleral Diseases |
General disorders of the sclera or white of the eye. They may include anatomic, embryologic, degenerative, or pigmentation defects. |
Sclera Diseases,Disease, Sclera,Disease, Scleral,Diseases, Sclera,Diseases, Scleral,Sclera Disease,Scleral Disease |
|
| D015423 |
Scleritis |
Refers to any inflammation of the sclera including episcleritis, a benign condition affecting only the episclera, which is generally short-lived and easily treated. Classic scleritis, on the other hand, affects deeper tissue and is characterized by higher rates of visual acuity loss and even mortality, particularly in necrotizing form. Its characteristic symptom is severe and general head pain. Scleritis has also been associated with systemic collagen disease. Etiology is unknown but is thought to involve a local immune response. Treatment is difficult and includes administration of anti-inflammatory and immunosuppressive agents such as corticosteroids. Inflammation of the sclera may also be secondary to inflammation of adjacent tissues, such as the conjunctiva. |
Episcleritis,Necrotizing Scleritis,Episcleritides,Necrotizing Scleritides,Scleritides,Scleritides, Necrotizing,Scleritis, Necrotizing |
|
| D016896 |
Treatment Outcome |
Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. |
Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes |
|
| D020327 |
Glaucoma Drainage Implants |
Devices, usually incorporating unidirectional valves, which are surgically inserted in the sclera to maintain normal intraocular pressure. |
Aqueous Humor Shunt,Aqueous Shunt,Aqueous Shunts,Baerveldt Implant,Baerveldt Implants,Glaucoma Drainage Implant,Glaucoma Filtration Implant,Glaucoma Filtration Implants,Krupin Valve,Krupin Valves,Aqueous Humor Shunts,Drainage Implant, Glaucoma,Drainage Implants, Glaucoma,Filtration Implant, Glaucoma,Filtration Implants, Glaucoma,Implant, Baerveldt,Implant, Glaucoma Drainage,Implant, Glaucoma Filtration,Implants, Baerveldt,Implants, Glaucoma Drainage,Implants, Glaucoma Filtration,Shunt, Aqueous,Shunt, Aqueous Humor,Shunts, Aqueous,Shunts, Aqueous Humor,Valve, Krupin,Valves, Krupin |
|